Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS)

CUSIP: 64134X201

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
11,508,976
Total 13F shares
1,572,533
Share change
+763,437
Total reported value
$6,880,388
Price per share
$4.54
Number of holders
18
Value change
+$3,297,217
Number of buys
9
Number of sells
7

Security key

64134X201

Report period

Q4 2025

Institutions

18

Top holders

10

Top shareholders of NRXS - Neuraxis, INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Brian P. Hannasch
13D/G
12%
1,144,374
$3,387,347 +$1,274,446 01 Jul 2025
AIGH Capital Management LLC
13F
Company
3.5%
400,000
$1,232,000 30 Sep 2025
13F
PARSONS CAPITAL MANAGEMENT INC/RI
13F
Company
1%
116,726
$359,517 30 Sep 2025
13F
VANGUARD GROUP INC
13F
Company
0.62%
71,632
$220,626 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.44%
50,836
$156,574 30 Sep 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.31%
35,627
$109,731 30 Sep 2025
13F
MONEY CONCEPTS CAPITAL CORP
13F
Company
0.29%
33,395
$102,857 30 Sep 2025
13F
STIFEL FINANCIAL CORP
13F
Company
0.22%
25,710
$79,187 30 Sep 2025
13F
XTX Topco Ltd
13F
Company
0.22%
25,396
$78,220 30 Sep 2025
13F
Wealthcare Advisory Partners LLC
13F
Company
0.13%
15,188
$46,779 30 Sep 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.13%
15,101
$47,000 30 Sep 2025
13F
LPL Financial LLC
13F
Company
0.09%
10,000
$30,800 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0.05%
5,802
$17,870 30 Sep 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
1,606
$4,946 30 Sep 2025
13F
Ulland Investment Advisors, LLC
13F
Company
0.01%
1,000
$3,000 30 Sep 2025
13F
Fortitude Family Office, LLC
13F
Company
0.01%
697
$2,147 30 Sep 2025
13F
CITIGROUP INC
13F
Company
0%
302
$930 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
67
$206 30 Sep 2025
13F
JPMORGAN CHASE & CO
13F
Company
0%
11
$34 30 Sep 2025
13F
Christopher Robin Brown
3/4/5
DIRECTOR OF INNOVATION, Director
class O/S missing
792,837
$2,069,305 08 Aug 2023
Gary Merril Peterson
3/4/5
DIR.OF DESIGN & ENGINEERING
class O/S missing
518,120
$1,352,293 08 Aug 2023

Institutional Holders of Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) as of Q4 2025

As of 31 Dec 2025, Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,572,533 shares. The largest 10 holders included AIGH Capital Management LLC, Rosalind Advisors, Inc., MONEY CONCEPTS CAPITAL CORP, Panoramic Capital, LLC, VANGUARD GROUP INC, PARSONS CAPITAL MANAGEMENT INC/RI, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 18 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
18
Q4 2025 holders
18
Holder diff
0
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .